Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Gefitinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Gefitinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Gefitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Gefitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Gefitinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib-d3 | Stable Isotopes | CS-T-100530 | 1603814-04-5(Unlabelled) | Enquire |
| Gefitinib D3 | Stable Isotopes | CS-T-55228 | 1173976-40-3 | Enquire |
| Gefitinib Morpholine N-oxide-d3 | Stable Isotopes | CS-T-100272 | Not Available | Enquire |
| Gefitinib-d8 | Stable Isotopes | CS-O-06643 | 857091-32-8 | In Stock |
| N-(3-Morpholinopropyl) Gefitinib-D8 | Stable Isotopes | CS-T-102201 | Not Available | Enquire |
| O-Desmethyl Gefitinib D8 | Stable Isotopes | CS-O-47487 | Not Available | Enquire |
| O-Desmethyl Gefitinib-d6 | Stable Isotopes | CS-T-100512 | Not Available | Enquire |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Gefitinib | API Standards | CS-O-11657 | 184475-35-2 | In Stock |
| Gefitinib dihydrochloride | API Standards | CS-O-31372 | 184475-56-7 | Enquire |
Metabolites
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Gefitinib Metabolite M527301 | Metabolites | CS-O-14010 | 1221965-74-7 | Enquire |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 3,11-dimethoxy-2,10-bis(3-morpholinopropoxy)-6-oxo-5,6-dihyd... | Impurities | CS-O-59012 | Not Available | Enquire |
| 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate | Impurities | CS-O-30859 | 179688-53-0 | In Stock |
| 3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib | Impurities | CS-T-15930 | 1603814-04-5 | In Stock |
| 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl ac... | Impurities | CS-O-31371 | 788136-89-0 | In Stock |
| 6-Hydroxy-7-methoxy-4(1H)-quinazolinone | Impurities | CS-O-14130 | 179688-52-9 | In Stock |
| 7-hydroxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate | Impurities | CS-O-58858 | Not Available | Enquire |
| Dimorpholinopropane | Impurities | CS-O-56669 | 48152-09-6 | Enquire |
| Gefitinib 3,4-Difluoro Impurity | Impurities | CS-EO-01647 | 184475-50-1 | Enquire |
| Gefitinib Chloro Impurity | Impurities | CS-O-47354 | 199327-59-8 | In Stock |
| Gefitinib Impurity 13 | Impurities | CS-O-56667 | 2254241-82-0 | Enquire |
| Gefitinib Impurity 14 | Impurities | CS-EO-03591 | 1383952-42-8 | Enquire |
| Gefitinib Impurity 36 | Impurities | CS-O-56666 | 134187-43-2 | Enquire |
| Gefitinib Impurity 37 | Impurities | CS-O-56717 | Not Available | Enquire |
| Gefitinib Impurity 8 | Impurities | CS-O-56712 | 2512211-98-0 | Enquire |
| Gefitinib Impurity 9 | Impurities | CS-O-56665 | 1608115-59-8 | Enquire |
| Gefitinib Impurity II | Impurities | CS-EO-01648 | 153437-78-6 | Enquire |
| Gefitinib Morpholine N-oxide | Impurities | CS-T-55229 | 847949-51-3 | In Stock |
| N-(3-Morpholinopropyl) Gefitinib TriHCl salt | Impurities | CS-EO-03590 | 1502829-45-9 (Freebase) | Enquire |
| O-Desmethyl Gefitinib | Impurities | CS-T-16242 | 847949-49-9 | Enquire |
EP Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Gefitinib for system suitability (Y0001809) | EP Standards | CS-EG-02367 | 184475-35-2 | Enquire |
Intermediates
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 4-(3-Chloropropyl)morpholine | Intermediates | CS-O-30855 | 7357-67-7 | In Stock |
| 4-Defluoro-4-hydroxy Gefitinib | Intermediates | CS-T-14768 | 847949-50-2 | Enquire |
| 5-Hydroxy-4-methoxy-2-nitrobenzoic acid | Intermediates | CS-M-43748 | 31839-20-0 | In Stock |
| Gefitinib Metabolite I | Intermediates | CS-T-16537 | 847949-56-8 | Enquire |
| Gefitinib-d6 | Intermediates | CS-T-96069 | 1228664-49-0 | Enquire |
| Linkable gefitinib analogue | Intermediates | CS-ED-39748 | 655247-75-9 | Enquire |
| N-(3-Morpholinopropyl) Gefitinib | Intermediates | CS-T-83087 | 1502829-45-9 | Enquire |
| O-Desmorpholinopropyl Gefitinib | Intermediates | CS-T-16536 | 184475-71-6 | In Stock |
Fine Chemicals
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 3-Chloro-4-fluoroaniline | Fine Chemicals | CS-M-00925 | 367-21-5 | In Stock |